The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study
ConclusionMetformin offers a therapeutic opportunity for controlling toxicities caused by neoadjuvant chemotherapy in non-diabetic breast cancer patients.Trial RegistrationThis randomised controlled trial was registered on November 20, 2019 in ClinicalTrials.gov under registration number: NCT04170465.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Diabetes | Drugs & Pharmacology | Endocrinology | Fatty Liver Disease (FLD) | Fortamet | Liver | Metformin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Oral Cancer | Peripheral Neuropathy | Study | Toxicology | Urology & Nephrology